+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Nabriva Therapeutics plc (NBRV) - Financial and Strategic SWOT Analysis Review

1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Nabriva Therapeutics plc (Nabriva), formerly Nabriva Therapeutics AG is a clinical stage biopharmaceutical company that discovers and develops pleuromutilin antibiotics for the treatment of infections caused by resistant pathogens. The company’s product candidate include lefamulin, a pleuromutilin antibiotic, is under development in both intravenous and oral formulations for the treatment of community-acquired bacterial pneumonia. It also develops BC-7013 for the topical treatment of a variety of gram-positive infections including uncomplicated skin and skin structure infections. The company also conducts research on evaluating extended-spectrum pleuromutilins, which are pleuromutilin compounds with enhanced activity against gram-negative bacteria. It partners with pharmaceutical and biotechnology companies. The company operates in Austria, the US and Ireland. Nabriva is headquartered in Dublin, Ireland.

Nabriva Therapeutics plc Key Recent Developments

May 08, 2018: Nabriva Therapeutics Reports First Quarter 2018 Financial Results and Recent Corporate Highlights
Apr 20, 2018: Antimicrobials Working Group Highlights Member Company Participation at the 28th European Congress of Clinical Microbiology and Infectious Diseases
Mar 21, 2018: Nabriva Therapeutics Names Jennifer Schranz As Chief Medical Officer
Mar 16, 2018: Nabriva Therapeutics Announces 2017 Financial Results
Dec 13, 2017: Nabriva Therapeutics Added to NASDAQ Biotechnology Index

This comprehensive SWOT profile of Nabriva Therapeutics plc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Nabriva Therapeutics plc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Product cover images may vary from those shown
Section 1 - About the Company
  • Nabriva Therapeutics plc - Key Information
  • Nabriva Therapeutics plc - Overview
  • Nabriva Therapeutics plc - Key Employees
  • Nabriva Therapeutics plc - Key Employee Biographies
  • Nabriva Therapeutics plc - Key Operational Heads
  • Nabriva Therapeutics plc - Major Products and Services
  • Nabriva Therapeutics plc - History
  • Nabriva Therapeutics plc - Company Statement
  • Nabriva Therapeutics plc - Locations And Subsidiaries
  • Nabriva Therapeutics plc - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Nabriva Therapeutics plc - Business Description
  • Nabriva Therapeutics plc - Corporate Strategy
  • Nabriva Therapeutics plc - SWOT Analysis
  • SWOT Analysis - Overview
  • Nabriva Therapeutics plc - Strengths
  • Nabriva Therapeutics plc - Weaknesses
  • Nabriva Therapeutics plc - Opportunities
  • Nabriva Therapeutics plc - Threats
  • Nabriva Therapeutics plc - Key Competitors
Section 3 - Company Financial Performance Charts
  • Nabriva Therapeutics plc - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • Nabriva Therapeutics plc, Key Information
  • Nabriva Therapeutics plc, Key Ratios
  • Nabriva Therapeutics plc, Share Data
  • Nabriva Therapeutics plc, Major Products and Services
  • Nabriva Therapeutics plc, History
  • Nabriva Therapeutics plc, Key Employees
  • Nabriva Therapeutics plc, Key Employee Biographies
  • Nabriva Therapeutics plc, Key Operational Heads
  • Nabriva Therapeutics plc, Other Locations
  • Nabriva Therapeutics plc, Subsidiaries
  • Nabriva Therapeutics plc, Key Manufacturing facilities
  • Nabriva Therapeutics plc, Key Competitors
  • Nabriva Therapeutics plc, SWOT Analysis
  • Nabriva Therapeutics plc, Ratios based on current share price
  • Nabriva Therapeutics plc, Annual Ratios
  • Nabriva Therapeutics plc, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Nabriva Therapeutics plc, Performance Chart
  • Nabriva Therapeutics plc, Ratio Charts
Note: Product cover images may vary from those shown